Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Hemiplegia? 146 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Hemiplegia have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.4% of all adverse event reports for DABIGATRAN ETEXILATE.

146
Reports of Hemiplegia with DABIGATRAN ETEXILATE
0.4%
of all DABIGATRAN ETEXILATE reports
13
Deaths
113
Hospitalizations

How Dangerous Is Hemiplegia From DABIGATRAN ETEXILATE?

Of the 146 reports, 13 (8.9%) resulted in death, 113 (77.4%) required hospitalization, and 26 (17.8%) were considered life-threatening.

Is Hemiplegia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 146 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Hemiplegia?

ASPIRIN (498) METFORMIN (374) ATORVASTATIN (307) AMLODIPINE (306) RIVAROXABAN (286) ESOMEPRAZOLE (284) IRBESARTAN (266) SITAGLIPTIN (256) METHOTREXATE (254) ACETAMINOPHEN (224)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Hemiplegia Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Hemiplegia Reports All Drugs Causing Hemiplegia DABIGATRAN ETEXILATE Demographics